http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2765838-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7993555f0f487d839882fd3533cb251c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06
filingDate 2021-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71adaf99a671b1853acae99d6054b741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b17290df3c1721db36f66dcee4fb5e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd2e413823ed8326d85d0b8f5e0d1f79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a3da00bb7e21199e5dcc02af8078446
publicationDate 2022-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2765838-C1
titleOfInvention Remedy for the treatment of postpartum mastitis and endometritis in cows
abstract FIELD: pharmaceutics.SUBSTANCE: invention relates to the field of pharmaceuticals, namely to a means for the treatment of a disease selected from postpartum mastitis and endometritis in cows. The product includes yotoin, retinol, dexamethasone, an aqueous extract of propolis, liquid paraffine as the base, at certain ratios.EFFECT: invention provides for the development of a new universal drug for the treatment of postpartum mastitis and endometritis in cows, which has a disinfecting, regenerative, antihistamine effect.1 cl, 8 tbl, 4 ex
priorityDate 2021-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2578464-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2102074-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590002

Total number of triples: 39.